IMPORTANT SAFETY INFORMATION FOR LATUDA

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warning.
  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are
    at an increased risk of death.
  • LATUDA is not approved for the treatment of patients with dementia-related psychosis.
Please click here for additional Important Safety Information, including Boxed Warning.
Please click here for full Prescribing Information.

Privacy Policy

Welcome to www.latuda.com, a Sunovion Pharmaceuticals Inc. and its U.S. subsidiaries and affiliates (together, the "Company") web site. Sunovion is committed to privacy for our web site users. Please be sure to read this Policy before using and submitting information on any of our web sites. Your use of any Sunovion Pharmaceuticals Inc. web site is subject to this Policy as well as the Terms of Use. By accessing and using any of our web sites you agree to be bound by the terms of this Policy.

This Policy may be subject to change. Any changes will be posted on this page. Should you have any questions, comments or concerns please contact us at: info@sunovion.com.

Collection of Information
Sunovion learns certain information about you from your visit to our web site, and what we do with this information depends on what you do when you are visiting the site. Unless you register and create a profile, send us an e-mail, or use chat rooms and forums or other products and services that are or will be available on our web site, we collect and store only the following information with the goal of improving the content and services offered on our web site: (i) the domain and host from which you access the Internet; (ii) the Internet address of the web site from which you linked directly to the Sunovion web site, if applicable; (iii) the date and time you arrived at our web site and how long you spent on the web site and which pages you visited; (iv) your Internet protocol (IP) address; and (v) your computer's operating system and browser software. Sunovion does not use this information to determine the individual identity of any web site visitor.

If you do register and create a profile, create a user name and password, send us an e-mail, or use the chat rooms and forums or other products and services that are or will be available on our web site, or otherwise voluntarily submit personally identifiable information to Sunovion, we will collect and store the information you enter. This information may be used by Sunovion personnel or a third party working on behalf of Sunovion as a means to contact you to obtain more information, to improve the site, or it might be used to provide you with information that you have requested or additional information that Sunovion believes may be of interest to you. Sunovion maintains the data collected in an electronic database. Sunovion or its agents may exchange such information with each other or with you over the Internet or intranet systems for the purposes of carrying out the services described in this Policy. In addition, Sunovion reserves the right to keep all information in an off-line form, for archival purposes or as otherwise required by law.

Use and Disclosure of Information
Sunovion does not provide personally identifiable information about our web site visitors to third parties except (i) to vendors and service providers who assist us in providing services to you; (ii) in connection with security related or law enforcement investigations or in the course of cooperating with authorities; (iii) to comply with legal requirements or to establish or exercise our legal rights or defend against legal claims; (iv) when we believe it is necessary to share information in order to assist in an investigation regarding, or to prevent, illegal activities, suspected fraud, or situations involving potential threats to the safety of any person; and (v) we may transfer such information upon a sale or merger of our business or upon a sale of assets that includes the web sites. Any vendor or service provider to whom we provide personally identifiable information is required to keep your information confidential.

We may use aggregate data (information about our base of users in general, from which all personally-identifying information has been removed) for any purpose.

Opting In / Permission To Contact You And/or Send You Materials and Information
Only when specifically requested by our web site visitors, will the information we collect be used to respond to visitors' inquiries and/or to send visitors information/newsletters, fulfill e-mail messaging programs, and notify visitors about new content or services on our web sites. In other words, it is only when you have specifically requested to receive such contact and information from us that we use any of your personally identifiable information.

Unsubscribing/Opting Out
If you decide you no longer wish to receive e-mail communications from Sunovion, you may opt out at any time by notifying us at 1-888-394-7377 or e-mailing cac@sunovion.com.

Contacting Us About Your Online Privacy
Web site visitors may always contact us to remove or update personally identifiable information from our database by sending an e-mail to us. If you have any questions or comments about the way your personally identifiable information collected via our web sites is used and handled, please e-mail us at info@sunovion.com.

Security
Sunovion takes reasonable precautions to keep all information obtained from web site visitors secure against unauthorized access and use. Please be aware, however, that there is always some risk involved when submitting data over the Internet.

Third-Party Web Sites
As a convenience to our web site visitors, our sites may contain links to third-party web sites. Third-party web sites are not covered by this Policy and Sunovion will have no control over the information you enter or the cookies your browser accepts while on third parties' sites. You should examine the terms of service and privacy policies of other web pages whenever you leave a Sunovion web site. Sunovion is not responsible for the privacy practices or the content included on third-party web sites.

Site/Membership Registration Forms
Our site's registration forms require users to give us contact information (like name and email address), and other demographic information. We use customer contact information from the registration forms to send the user information about our Sunovion and/or our products. The customer's contact information is also used to contact the visitor when necessary.

Contest
We may run contest on some sections of our site in which we ask visitors for contact information (like email address) and demographic information. The customer's contact information is also used to contact the visitor when necessary (e.g., prize distribution).

Advertising
We may use an outside ad company to display ads on our site. These ads may contain cookies. While we use cookies in other parts of our web site, cookies received with banner ads are collected by our ad Sunovion and are used for advertisement banner rotation purposes only.

Public Forums
This site may make chat rooms, forums, List Serves and message boards available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information. Sunovion cannot ensure or warrant the security of any information provided by you in such forums, and you do so at your own risk.

Children
Our web sites are intended for use by U.S. adults and young adults only. We do not knowingly collect information from children under the age of 18.

Use of "Cookies"
Our site uses cookies to maintain user session identity, and to store your username and password locally for ease of access. "Cookies" are small pieces of information that are stored by your browser on your computer's hard drive. Most web browsers automatically accept cookies, but if you prefer, you can edit your browser options to block them in the future; however, if you disable cookies, our web site will not remember your customizations and cannot help you find what you want on the site most easily. If you accept cookies, you can delete them later by going to the preferences, tools or options menus of your browser.

IMPORTANT SAFETY INFORMATION FOR LATUDA

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warning.

  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. 
  • LATUDA is not approved for the treatment of patients with dementia-related psychosis.

Neuroleptic malignant syndrome (NMS): NMS is a rare and potentially fatal side effect reported with LATUDA and similar medicines. Call your healthcare provider right away if you have high fever; stiff muscles; confusion; changes in pulse, heart rate, or blood pressure; sweating; or muscle pain and weakness. Treatment should be stopped if you have NMS.

Tardive dyskinesia (TD): TD is a serious and sometimes permanent side effect reported with LATUDA and similar medicines. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk for developing TD and the chance that it will become permanent is thought to increase the longer a person takes the medicine and the more medicine a person takes over time. TD can develop after a person has been taking the medicine for a short time at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if the person stops taking the medicine.

Metabolic Changes

High blood sugar: High blood sugar and diabetes have been reported with LATUDA. If you have diabetes or risk factors for diabetes, such as being overweight or a family history of diabetes, your blood sugar should be tested at the beginning of and throughout treatment with LATUDA. Complications of diabetes can be serious and even life threatening. Tell your healthcare provider if you have blood sugar problems or signs of diabetes, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry.

High cholesterol and triglycerides: Undesirable alterations in lipids have been observed in patients treated with atypical antipsychotics.

Weight gain: Some patients may gain weight while taking LATUDA. Your healthcare provider should check your weight regularly. Talk to your healthcare provider about ways to help control your weight, such as eating a healthy, balanced diet and exercising.

Additional Important Warnings

Pregnancy: Tell your healthcare provider if you are pregnant or if you are planning to get pregnant while taking LATUDA. Breast feeding is not recommended during treatment with LATUDA.

Tell your healthcare provider about all prescription and over-the-counter medicines you are taking or plan to take, since there are some risks for drug interactions with LATUDA. Avoid drinking alcohol while taking LATUDA.

In people with schizophrenia, the most common side effects that occurred with LATUDA were sleepiness, an inner sense of restlessness or need to move (akathisia), upset stomach, and movement abnormalities such as tremors, slow movement, or muscle stiffness (parkinsonism). 

This is not a complete summary of safety information. Please discuss the full Prescribing Information for prescription LATUDA with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Sunovion

 

You are now leaving the LATUDA website. Sunovion is not responsible for the information contained in any of the linked sites.